MedX Health (MDXHF) Stock Analysis & Winston Score
MedX Health Corp is a small Canadian healthcare technology company that makes devices and software for examining skin. Its main product is a handheld device called SIAscopy, which uses light to scan moles and skin lesions and help doctors decide if something might be skin cancer. The main customers are doctors, dermatologists, and clinics looking for tools to catch skin problems early. The company earns money by selling its scanning devices and through service or software fees tied to those devices. MedX operates primarily in Canada and is working to expand into other markets, including the United States and Europe. It is a very small company with a negative gross margin, meaning it currently costs more to deliver its products than it earns from them, which is a significant financial risk. The key challenge ahead is reaching enough scale to cover its costs, as the company depends heavily on growing its customer base to become financially sustainable.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Weak (4/30)
- Growth: Weak (4/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)

